Ayman Akil
Senior Manager, A&G Consultancy – Middle East, North Africa and Turkey
Dr. Akil has more than 12 years of experience in academia, corporate R&D industries and cross-collaborations. He has specialized in strategic planning for research enterprises, including the analyses associated with university rankings. His consulting projects aim at designing and implementing strategies for various research entities to optimize their activities and processes as well as enhance their performance assessment models. Dr. Akil has implemented several national capacity building activities for upskilling researchers, academics and decision makers through targeted workshops and academies. Prior to joining Clarivate, Dr. Akil was a researcher at the Max-Planck Institute for Quantum Optics in Germany.
Latest news
Clarivate Scales Agentic AI Across Cortellis to Advance Drug Development
Expanded capabilities across Cortellis portfolio help life sciences organizations turn trusted intelligence into action and accelerate decision making across the research and development lifecycle London, U.K. — August 6, 2026— Clarivate…
Clarivate Companies to Watch Report Spotlights Seven Innovators Shaping the Next Generation of Obesity Therapies
New report examines novel mechanisms and emerging approaches advancing obesity treatment beyond today’s GLP-1 therapies London, U.K., August 5, 2026 — Clarivate Plc (NYSE:CLVT), a leading global provider of transformative…
Clarivate Appoints Michael Easton as Chief Financial Officer
Experienced Clarivate leader brings more than 25 years of financial and operational expertise LONDON, July 29, 2026: Clarivate Plc (NYSE: CLVT) (“Clarivate” or the “Company”), a leading global provider of transformative intelligence, today…